Kyle Rose
Stock Analyst at Canaccord Genuity
(2.60)
# 2,108
Out of 5,146 analysts
115
Total ratings
51.61%
Success rate
13.15%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $245.25 | +83.49% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $35.97 | -24.94% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $381.33 | +14.07% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $91.88 | -22.73% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $22.88 | +210.31% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $13.98 | +57.37% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $0.89 | +1,019.82% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $13.93 | +57.93% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $73.09 | +105.23% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.01 | +13,332.84% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $15.29 | +76.59% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.78 | +1,815.71% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $32.50 | -53.85% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $155.36 | -21.47% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.77 | -16.14% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.72 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $99.87 | +25.16% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $245.25
Upside: +83.49%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $35.97
Upside: -24.94%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $381.33
Upside: +14.07%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $91.88
Upside: -22.73%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $22.88
Upside: +210.31%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $13.98
Upside: +57.37%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.89
Upside: +1,019.82%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $13.93
Upside: +57.93%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $73.09
Upside: +105.23%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.01
Upside: +13,332.84%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $15.29
Upside: +76.59%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.78
Upside: +1,815.71%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $32.50
Upside: -53.85%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $155.36
Upside: -21.47%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.77
Upside: -16.14%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $8.72
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $99.87
Upside: +25.16%